Related Experiment Video
Updated: Mar 24, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer
Rong-Liang Shi1, Ning Qu1, Tian Liao1
1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China.
Abstract:
Thyroid cancer is a common endocrine malignancy. The last decade has seen exciting progress in understanding thyroid cancer molecular pathogenesis. Several major signaling pathways and related molecular derangements have been elucidated, which represent novel diagnostic and prognostic molecular markers for thyroid cancer. Based on the molecular biology of thyroid cancer, a series of therapeutic targets have been developed, which provide unprecedented opportunities. Thus, histological characterization of subgroups of patients and the correct molecular characterization of patients are thought to be key aspects for future clinical management of these patients. In the present study, we identified Slit2 as a prognostic marker for thyroid cancer oncogenesis and recurrence. Mechanistically, Slit2 regulated Warburg effect in thyroid cancer cells through regulation of HIF1α and HIF1α transcriptional activity. Taken together, our present data uncovered Slit2 as a novel predictive marker for thyroid cancer. The mechanism study indicated that Slit2 regulated the Warburg effect. Additional study on the function of Slit2 in thyroid cancer is required to provide new insights into the potential mechanisms of oncogenesis and recurrence potential of thyroid cancer.
Insights
Slit2 is identified as a novel prognostic marker for thyroid cancer, impacting oncogenesis and recurrence. This protein regulates the Warburg effect in thyroid cancer cells by influencing HIF1α activity.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Thyroid cancer is a common endocrine malignancy with significant progress in understanding its molecular pathogenesis.
- Elucidation of signaling pathways and molecular derangements offers novel diagnostic, prognostic, and therapeutic targets for thyroid cancer.
Purpose of the Study:
- To identify novel molecular markers for thyroid cancer oncogenesis and recurrence.
- To investigate the mechanistic role of Slit2 in thyroid cancer progression.
Main Methods:
- Identification of Slit2 as a prognostic marker.
- Mechanistic studies on Slit2's regulation of the Warburg effect.
- Analysis of Slit2's impact on HIF1α and its transcriptional activity in thyroid cancer cells.
Main Results:
- Slit2 was identified as a significant prognostic marker for thyroid cancer oncogenesis and recurrence.
- Slit2 was found to regulate the Warburg effect in thyroid cancer cells.
- Regulation occurred through modulation of HIF1α and its transcriptional activity.
Conclusions:
- Slit2 emerges as a novel predictive marker for thyroid cancer.
- Slit2's role in regulating the Warburg effect provides insights into thyroid cancer mechanisms.
- Further research on Slit2 function is needed for potential therapeutic strategies.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation